← Back to Clinical Trials
Recruiting NCT06444854

NCT06444854 Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06444854
Status Recruiting
Phase
Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition Lung Surgery
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2024-10-22
Primary Completion 2026-11-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
early chest tube removal

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2024-10-22 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a single centre, prospective clinical trial evaluating the safety and feasibility of implementing a same day chest tube removal protocol in patients undergoing Video Assisted Thoracic Surgery (VATS) anatomical pulmonary surgery.

Eligibility Criteria

Inclusion Criteria: * 18 yrs or older * scheduled to undergo elective VATS segmental or lobar resection of the lung Exclusion Criteria: * Pulmonary function tests demonstrating forced expiratory volume in 1 second Forced Expiratory Volume (FEV1) \<50% predicted, FEV1 \<1.5L and/or diffusion lung capacity of carbon monoxide Lung Diffusion Test (DLCO) \<50% predicted * Patient receives an intraoperative pleurodesis * Conversion to open thoracotomy or mini thoracotomy intraoperatively. * Underlying cognitive disorder resulting in inability to complete activities of daily living.

Contact & Investigator

Central Contact

Deb Lewis

✉ deb.lewis@lhsc.on.ca

📞 5196858500

Principal Investigator

Rahul Nayak, MD MSc

PRINCIPAL INVESTIGATOR

Western University

Frequently Asked Questions

Who can join the NCT06444854 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06444854 currently recruiting?

Yes, NCT06444854 is actively recruiting participants. Contact the research team at deb.lewis@lhsc.on.ca for enrollment information.

Where is the NCT06444854 trial being conducted?

This trial is being conducted at London, Canada.

Who is sponsoring the NCT06444854 clinical trial?

NCT06444854 is sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. The principal investigator is Rahul Nayak, MD MSc at Western University. The trial plans to enroll 130 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology